Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. [electronic resource]
Producer: 20150316Description: 244-50 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- BRCA1 Protein -- genetics
- BRCA2 Protein -- genetics
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Germ-Line Mutation
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Pancreatic Neoplasms -- drug therapy
- Phthalazines -- administration & dosage
- Piperazines -- administration & dosage
- Prospective Studies
- Prostatic Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.